Biotech Companies Attractive Targets for Pharmaceutical Companies Looking to Replace Lost Revenues

February 6, 2013
Lost revenues from expiring patents have played a major part in the biotech industry's success in recent years. A total of 676 takeovers of biotechnology and pharmaceutical companies have occurred in the past three years, with an average premium of 38 percent, according to data collected by Bloomberg.